Article

syndication.washingtonpost.comsyndication.washingtonpost.com on 2023-09-13 18:11

Moderna poised to seek flu shot approval after trial results - Wed, 13 Sep 2023 PST

Moderna said a reformulated version of its messenger-RNA based flu shot met its primary goals in a final-stage trial – a result that could pave the ...

Related news